Nom du produit:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one
IUPAC Name:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one
- CAS:2763157-90-8
- Formule moléculaire:C8H4Cl2FN3OS
- Pureté:95%+
- Numéro de catalogue:CM1043992
- Poids moléculaire:280.1
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2763157-90-8
- Formule moléculaire:C8H4Cl2FN3OS
- Point de fusion:-
- Code SMILES:CSC1=NC2=C(C(=O)N1)C(=NC(=C2F)Cl)Cl
- Densité:
- Numéro de catalogue:CM1043992
- Poids moléculaire:280.1
- Point d'ébullition:
- N° Mdl:
- Stockage:
Column Infos
- HRS-4642
- HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor, with an affinity constant of 0.083 nM. HRS-4642 demonstrated robust efficacy against KRAS G12D-mutant cancers both in vitro and in vivo. Importantly, in a phase 1 clinical trial, HRS-4642 exhibited promising anti-tumor activity in the escalating dosing cohorts. Furthermore, the sensitization and resistance spectrum for HRS-4642 was deciphered through genome-wide CRISPR-Cas9 screening, which unveiled proteasome as a sensitization target. HRS-4642, either as a single agent or in combination with carfilzomib, reshaped the tumor microenvironment toward an immune-permissive one.